Consistent with the observation in HNSCC, the lung SCC patients with amplification and overexpression of FADD under conventional treatments also had worse disease/progression-free survival from TCGA datasets (Supplemental Figure 3C). This evidence concerns the gene FADD and head and neck squamous cell carcinoma.